HepQuant
Pre-clinicalWe have developed noninvasive, blood-based, quantitative tests that assess liver health by measuring critical liver cell processes and blood flow to the liver. Our test results support healthcare providers’ clinical decisions to achieve more effective management of patients with advanced liver disease. HepQuant DuO testing delivers a Disease Severity Index (DSI), assessing a patient’s current level of liver impairment and disease state. Results may be used by healthcare providers in conjuncti...
About
We have developed noninvasive, blood-based, quantitative tests that assess liver health by measuring critical liver cell processes and blood flow to the liver. Our test results support healthcare providers’ clinical decisions to achieve more effective management of patients with advanced liver disease. HepQuant DuO testing delivers a Disease Severity Index (DSI), assessing a patient’s current level of liver impairment and disease state. Results may be used by healthcare providers in conjuncti...
Funding History
2Total raised: $5.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile